Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Clinical trial NCT06629376 · RECRUITING
Trial details
- NCT number
- NCT06629376
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2026-12-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.